Burnout Recovery

Burnout Recovery: A Nutritional and Natural-Health Reference

1. Definition and Classification

The 11th revision of the World Health Organization's International Classification of Diseases (ICD-11) defines burnout as "a syndrome conceptualized as resulting from chronic workplace stress that has not been successfully managed." It is not classified as a medical condition and is described in the chapter "Factors influencing health status or contact with health services." It is characterized by three dimensions: feelings of energy depletion or exhaustion; increased mental distance from one's job, or feelings of negativism or cynicism related to one's job; and reduced professional efficacy.

ICD-11 stresses that burnout "refers specifically to phenomena in the occupational context and should not be applied to describe experiences in other areas of life." Burnout is not recognized as a distinct mental disorder in the DSM-5 (published in 2013).

The WHO's definition of burnout closely corresponds to the definition inscribed in the Maslach Burnout Inventory, the most widely used measure of the entity. The Maslach Burnout Inventory approaches burnout as a syndrome induced by insurmountable work-related stress comprising symptoms of exhaustion, cynicism, and inefficacy. Exhaustion is considered burnout's core. Released in 1981, the Maslach Burnout Inventory was the first standardized quantitative measure of burnout.

2. Clinical Presentation

Burnout syndrome is characterized by three core dimensions: emotional exhaustion, depersonalization, and a lack of personal accomplishment. Emotional exhaustion refers to the feeling of being emotionally overextended and depleted of one's emotional resources. Depersonalization involves developing a cynical attitude and feelings of detachment from one's job and the people involved.

Burnout syndrome comprises emotional exhaustion, physical fatigue, and cognitive weariness. Prolonged stress of six months or more may cause a condition which has been named exhaustion disorder (ED), characterized by exhaustion, cognitive problems, poor sleep, and reduced tolerance to further stress.

Persistent burnout is a cause of reduced quality of life and is associated with increased risk of sleep impairment and with several medical disorders including mild cognitive impairment, diabetes, and cardiovascular disease.

3. Body Systems Involved

3.1 The Neuroendocrine System: HPA Axis

There is mounting evidence that burnout is a risk factor for cardiovascular disease (CVD). Stress-related dysregulation of the sympathetic and parasympathetic system and the hypothalamic pituitary adrenal (HPA) axis may explain the enhanced risk for CVD.

Research on the HPA axis in burnout has produced inconsistent findings. Burnout is associated primarily with a hypofunction of the HPA axis, which is a neuro-endocrine characteristic of exhaustion rather than of depression. Functional stress testing showed hypersuppression of the HPA axis after dexamethasone, while basal cortisol values were less conclusive, although a meta-analysis pointed to a negative association between burnout and cortisol.

However, other studies complicate this picture. Burnout patients showed higher resting heart rate than healthy controls. Basal cortisol levels and cortisol reactivity and recovery measures were similar for burnout patients and healthy controls; however, burnout patients showed elevated cortisol levels during the first hour after awakening in comparison to healthy controls. Several studies have investigated the association between burnout and HPA axis functioning, but the results are far from consistent.

Burnout is characterised by dysregulation of the sympathetic and parasympathetic system and the HPA axis, which was more pronounced in males than in females. In male patients, baseline systolic blood pressure was higher, whereas basal alpha-amylase and cortisol reactivity were lower than in healthy males. In female patients, a tendency for lower basal cortisol was found as compared to healthy females. Furthermore, reduced basal heart rate variability and a trend for elevated basal cardiac output were observed in both male and female patients.

3.2 The Brain and Nervous System

Persistent clinical burnout is associated with a reduction in the volume of gray matter of the anterior cingulate cortex and dorsolateral prefrontal cortex as well as in the volume of the caudate and putamen structures, with reduced dendritic arborization and number of dendritic spines and reduced synaptic density. Persistent burnout is also related to an increase in the structural volume of the amygdala; a reduction in 5-HT1A receptor binding in the limbic structures, hippocampus, and anterior cingulate cortex; and with interconnective dysfunctional regulatory activity between the amygdala, anterior cingulate cortex, and medial prefrontal cortex.

The HPA axis is interconnected with other neuroendocrine networks, and together, these regulate cognition, emotion, mood, sleep, and mental energy resources. Furthermore, it has been reported that clinical burnout is associated with functional dysregulation of inflammatory responses and with elevated levels of proinflammatory cytokines and markers of inflammation.

The neurotoxic effects of persistent stress-induced morphological changes and of functional dysregulation of neural pathways may explain the symptoms of clinical burnout, including impaired executive functioning.

3.3 The Immune System and Inflammation

Burnout leads to alteration in autonomic, endocrine, and immune systems marked by deranged levels of various hormones and immune markers. It is also reflected as neuroimaging changes in various brain structures and may manifest as cognitive symptoms. Consequences of burnout include increased allostatic load, structural and functional brain changes, excitotoxicity, systemic inflammation, immunosuppression, metabolic syndrome, cardiovascular disease, and premature death.

Higher levels of DHEAS and the monocyte-released anti-inflammatory cytokine IL-10 were observed, and the increased IL-10 level may be related to an increased sensitivity for infections.

3.4 Sleep Architecture

Sleep disruption is both a symptom and a driver of the process. Chronic stress interferes with REM sleep, the stages most involved in memory consolidation and emotional regulation. Poor sleep raises cortisol further, which impairs sleep quality again. Over weeks and months, this feedback loop compounds the cognitive and emotional effects of burnout considerably.

3.5 Cardiovascular and Musculoskeletal Systems

Research has linked burnout to a higher risk of cardiovascular events, including coronary heart disease, and to greater susceptibility to infectious illness due to immune suppression.

Increased levels of burnout during 18 months of follow-up were associated with an increased risk of developing musculoskeletal pain. Workers with high burnout levels had more than twice the risk of developing musculoskeletal pain compared to those without burnout.

4. Contributing and Associated Factors

4.1 Occupational and Organizational Factors

High levels of job stress, low job satisfaction, and inadequate communication are primary occupational risk factors contributing to burnout. Long working hours, shift work, and high patient acuity are significant organizational stressors contributing to burnout.

Severe stress and high levels of stress may almost quadruple the risk for burnout. Other significant predictors of burnout include traumatic work-related experience, mobbing, and higher workload.

The Job Demands–Resources (JD-R) model holds that every profession has unique risk factors connected to work-related stress. These factors fall into two broad categories: job demands and job resources, yielding a comprehensive, holistic model that can be applied to a variety of occupational settings.

4.2 Personal and Psychological Factors

Burnout syndrome comprises emotional exhaustion, physical fatigue, and cognitive weariness. Both exogenous work-related and endogenous personal factors determine the extent and the severity of symptoms in burnout syndrome.

Health professionals, particularly those in high-stakes environments, are especially vulnerable due to chronic workplace pressures, high job demands, and limited resources. While the prevalence and risk factors of burnout are well-documented, early warning signs often go unrecognized until the condition becomes chronic.

4.3 Digital and Modern Lifestyle Factors

Constant digital connectivity has eroded the natural boundaries between work and rest. For many people, particularly those in professional or academic settings, the expectation of availability extends well into evenings and weekends.

5. Nutrients Studied in Relation to Burnout Recovery

5.1 Magnesium

Scientific Evidence: Animal and clinical studies suggest complementary effects of magnesium and high-dose pyridoxine (vitamin B6) on stress reduction. A randomized trial evaluated the effects of combined magnesium and vitamin B6 supplementation on stress in a stressed population with low magnesemia using a validated measure of perceived stress.

Low serum magnesium concentrations increase the release of stress-associated hormones including catecholamines, adrenocorticotrophic hormone, and cortisol in response to stress, and affect their access to the brain, creating a vicious circle of reduced resistance to stress and further magnesium depletion.

In a double-blind, randomized trial of 46 healthy adults aged 60–75 years, magnesium supplementation (500 mg per day administered as magnesium oxide tablets for 8 weeks) improved subjective measures of insomnia, which is recognized as a symptom of stress.

Primary findings from a recent study reported that magnesium supplementation significantly reduced stress in severely stressed subjects with low magnesemia, and additional vitamin B6 enhanced this effect. This trial was an 8-week Phase IV investigator-blinded, parallel-group design (EudraCT: 2015-003749-24), comparing magnesium + vitamin B6 to magnesium alone in adults with elevated DASS-42 stress scores and low magnesemia.

The overall evidence base for magnesium in stress-related conditions is promising but limited by relatively small sample sizes, heterogeneous populations, and short trial durations. Studies frequently focus on stressed or low-magnesemia populations rather than on clinically diagnosed burnout specifically.

5.2 B-Complex Vitamins

Scientific Evidence: B vitamins, particularly B6, folate (B9), and B12, are involved in the synthesis of neurotransmitters and the metabolism of stress hormones. Animal and clinical studies suggest complementary effects of magnesium and high-dose pyridoxine (vitamin B6) on stress reduction.

An 8-week Phase IV randomised, investigator-blinded, parallel-group trial compared the combination of magnesium and vitamin B6 with magnesium alone. The combined intervention outperformed magnesium alone in subjects with severe stress and low magnesemia, though the study focused on general perceived stress rather than clinically diagnosed burnout.

The direct evidence for B vitamins specifically in burnout recovery populations remains preliminary. Most supporting research uses broader stress or fatigue outcome measures and does not isolate burnout as a defined clinical endpoint.

5.3 Omega-3 Polyunsaturated Fatty Acids (EPA and DHA)

Scientific Evidence: Clinical studies have revealed that subjects diagnosed with depression or anxiety display significantly lower levels of omega-3 PUFAs and a higher ratio of omega-6 to omega-3 PUFAs in the blood and in the brain. Because burnout overlaps symptomatically with depression, including fatigue, anhedonia, and cognitive impairment, omega-3 research in depression and inflammation carries indirect relevance.

There is a growing body of evidence indicating that inflammation plays a causal role in the etiology of some forms of depression and may be associated with specific symptoms including anhedonia, fatigue, and psychomotor slowing. Recent studies have observed that higher doses of omega-3 fatty acids may be particularly effective for the treatment of depression in individuals with markers of high inflammation, and that the antidepressant effects of omega-3 fatty acids appear to be related to their potent anti-inflammatory effects.

Consistent evidence indicates that EPA-enriched formulations (≥60%) exert antidepressant effects, particularly in patients with elevated inflammatory markers (CRP, IL-6, TNF-α). In contrast, DHA-only preparations show limited efficacy. However, the literature remains heterogeneous in design, sample size, and biomarker stratification, which limits generalizability. While omega-3 fatty acids represent promising adjunctive interventions for mood disorders, methodological weaknesses and inconsistent formulations hinder definitive conclusions.

More than 30 clinical trials have tested different omega-3 preparations in people with depression. Most studies have used omega-3s as add-on therapy for people taking prescription antidepressants with limited or no benefit. Fewer studies have examined omega-3 therapy alone. Direct clinical trials in burnout-specific populations are lacking; the relevance of omega-3 evidence to burnout recovery is therefore inferential, based on shared biological pathways of inflammation and mood dysregulation.

5.4 Vitamin D

Scientific Evidence: Vitamin D is crucial for maintaining bone health and has been shown to play a role in reducing the risk of various diseases, including cardiovascular disease, cancer, autoimmune disorders, and infections. Previous research indicates that vitamin D affects sleep through the presence of 1α-hydroxylase and 1,25-dihydroxyvitamin D receptors (VDR) in the brain. Studies show that 1,25-dihydroxyvitamin D can regulate the expression of circadian clock genes such as BMAL1 and PER2.

A systematic review and meta-analysis of dietary supplement interventions found that tryptophan, vitamin D, omega-3, zinc, and antioxidants may enhance sleep quality by decreasing sleep latency and wakefulness after sleep onset, increasing sleep efficiency, and extending total sleep time. Because disrupted sleep is a key driver of burnout, vitamin D's influence on sleep architecture is a relevant avenue of inquiry, though direct burnout-specific trial data are absent.

6. Herbs and Botanical Ingredients

6.1 Ashwagandha (Withania somnifera)

Traditional Use: Withania somnifera, widely known as "Ashwagandha," is a key treatment herb in the Indian system of medicine that has been used for thousands of years. Ashwagandha, botanically known as Withania somnifera Dunal, is a member of the Solanaceae family. In Ayurvedic medicine, it is classified as a rasayana (rejuvenating tonic) and used to promote vitality, reduce fatigue, and enhance resilience to physical and mental stress. Ashwagandha is a member of the family of herbs referred to as "adaptogens," that is, substances that regulate metabolism when a body is perturbed by physical or mental stress and help the body to adapt to this stress.

Scientific Evidence: It has anti-inflammatory, neuroprotective, adaptogenic, and immunomodulatory activities. Ashwagandha contains a range of constituents including withanolides, sitoindosides, and other alkaloids that are pharmacologically and medicinally important.

In a single-center, prospective, double-blind, randomized, placebo-controlled trial, 64 subjects with a history of chronic stress were enrolled. The treatment group given high-concentration full-spectrum ashwagandha root extract exhibited a significant reduction (P<0.0001) in scores on all stress-assessment scales on Day 60, relative to the placebo group. The serum cortisol levels were substantially reduced (P=0.0006) in the ashwagandha group relative to the placebo group.

In a 60-day, randomized, double-blind, placebo-controlled study, the stress-relieving and pharmacological activity of an ashwagandha extract was investigated in stressed, healthy adults. Sixty adults were randomly allocated to take either a placebo or 240 mg of a standardized ashwagandha extract (Shoden) once daily. Outcomes were measured using the Hamilton Anxiety Rating Scale (HAM-A), Depression, Anxiety, and Stress Scale -21 (DASS-21), and hormonal changes in cortisol, DHEA-S, and testosterone. Ashwagandha supplementation was associated with a statistically significant reduction in HAM-A (P = .040) and was also associated with greater reductions in morning cortisol (P < .001) and DHEA-S (P = .004) compared with the placebo.

According to a systematic review of human trials, among many different supplements, ashwagandha has the most profound effect on the hypothalamic-pituitary-adrenal (HPA) axis. This effect on the HPA axis — a main regulator of the stress response — is evident through lowered morning cortisol levels. A recent systematic review demonstrated that supplementation with 250–500 mg of ashwagandha extract daily for 4 to 13 weeks significantly decreased morning cortisol levels in adults experiencing higher stress levels.

A 2024 meta-analysis searched RCTs from inception through September 2024 across PubMed, Web of Science, Scopus, and Cochrane databases. The findings showed a significant effect of ashwagandha formulations on the Perceived Stress Scale (PSS) (MD = −4.72), Hamilton Anxiety Scale (MD = −2.19), and serum cortisol levels (MD = −2.58) compared to placebo. Among the included studies, four reported mild to moderate adverse events. The findings indicate that ashwagandha formulations have beneficial effects on stress and anxiety, though further information is required to determine its safety with long-term administration.

A randomized controlled trial demonstrated the stress-reduction capabilities of an aqueous extract of ashwagandha (root and leaf) at the low dose of 125 mg/day, in a dose-dependent manner, via the modulation of the HPA axis. The extract dose-dependently and significantly attenuated stress as assessed by the Perceived Stress Scale and reduced levels of well-known biomarkers related to stress, such as plasma cortisol, ACTH, and salivary α-amylase.

Evidence strength: Moderate. Multiple RCTs and at least two meta-analyses support reductions in perceived stress and cortisol biomarkers in healthy stressed adults. However, most trials are short-term (8–13 weeks), involve relatively small sample sizes, and are conducted in generally stressed (not specifically burned-out) populations. Larger trials with longer follow-up and burnout-specific populations are needed. Ashwagandha's stress-relieving effects may occur via its moderating effect on the HPA axis; however, further investigation utilizing larger sample sizes, diverse clinical and cultural populations, and varying treatment dosages are needed to substantiate these findings.

6.2 Rhodiola rosea

Traditional Use: Rhodiola rosea is an adaptogen herb from the Crassulaceae family which has been widely used in Russian and Chinese medicine. The herb is used against depression, anxiety, mental and physical fatigue, and to promote overall health. Historically, it was used by Siberian and Scandinavian populations at high altitudes, where it was prepared as a decoction from roots and rhizomes. It was employed by athletes, soldiers, and workers to enhance physical endurance and mental performance under demanding conditions.

Scientific Evidence: A multicenter, open-label, exploratory clinical trial was the first to aim at exploring clinical outcomes in burnout patients treated with Rhodiola rosea. The reported capacity of R. rosea to strengthen the organism against stress and its good tolerability offer a promising approach in the treatment of stress-related burnout. Because this was an open-label, single-arm trial, it was explicitly designed to generate hypotheses for future randomized trials rather than to provide confirmatory evidence.

In clinical studies, Rhodiola rosea has shown positive results for treating chronic fatigue and burnout symptoms, improving fatigue scores, cognitive focus, and functional capacity. Clinical studies demonstrate that R. rosea reduces stress, fatigue, and burnout, indicating that the herb affects the immune system through HPA axis regulation. Preclinical results demonstrate R. rosea's ability to provide anti-inflammatory effects, antioxidant benefits, and support mitochondrial function.

A 2012 systematic review in BMC Complementary Medicine identified 206 articles; 206 unique articles were identified from the search and 11 met final inclusion criteria. Of those, 10 were described as randomized controlled trials and one was a controlled clinical trial. Six studies examined the effect of R. rosea on physical performance and five assessed mental fatigue. None of the studies examining R. rosea examined physical or mental fatigue measuring outcomes consistently — no two studies reported the same outcomes — such that meta-analysis could not be performed.

Research regarding R. rosea efficacy is contradictory. While some evidence suggests the herb may be helpful for enhancing physical performance and alleviating mental fatigue, methodological flaws limit accurate assessment of efficacy.

The majority of studies are related to the efficacy of R. rosea in terms of cognitive functions and mental performance, including various symptoms of life-stress, fatigue, and burnout. The beneficial effects on enhancing physical performance have also been evaluated in professional athletes and non-trained individuals. Moreover, even though most evidence originates from pre-clinical trials, several clinical studies have additionally demonstrated the remediating effects of R. rosea on cardiovascular and reproductive health. Overall, the results presented provide an encouraging basis for the clinical efficacy of R. rosea preparations in managing various aspects of stress-induced conditions.

Evidence strength: Preliminary to moderate. The most relevant direct evidence (the open-label burnout trial) is exploratory and lacks a control arm. RCT evidence in general fatigue populations is positive but methodologically heterogeneous; no two trials used the same outcome measures, preventing pooled meta-analysis. Findings are encouraging but not yet confirmatory for burnout-specific recovery.

6.3 Multi-Herb Adaptogen Combinations (Rhodiola, Holy Basil, Schisandra)

Scientific Evidence: Chronic stress is detrimental to the maintenance of the HPA axis. A 60-day randomized, double-blind, placebo-controlled clinical study investigated the efficacy of two plant-based adaptogens: a formula containing Rhodiola, holy basil, and Schisandra chinensis, and a full-spectrum ashwagandha, on stress and related symptoms in individuals with high stress. 186 participants were randomized to one of the adaptogens or to placebo. The study concluded that both formulas were associated with reductions in stress, fatigue, and anxiety while improving mood and sleep quality. This trial was industry-registered on ClinicalTrials.gov (NCT05602389) and represents a relatively recent, adequately powered study, though it was not confined to a burnout-diagnosed population.

7. Dietary Factors Discussed in Authoritative Sources

7.1 Overall Dietary Pattern

No single authoritative source currently prescribes a specific diet for burnout recovery. However, the literature on the physiological consequences of burnout — chronic inflammation, HPA axis dysregulation, neuroendocrine disruption, and sleep impairment — points to dietary strategies documented in peer-reviewed research on stress, inflammation, and mental health more broadly.

Deficiency or an imbalanced omega-6/omega-3 ratio, typical of Western diets, has been associated with an increased risk of mood disorders, such as major depression and bipolar disorder. Given the overlap between burnout and inflammatory-depression phenotypes, minimizing excess omega-6 fatty acid intake while increasing dietary sources of omega-3 fatty acids (e.g., oily fish, walnuts, flaxseed) is supported indirectly by this evidence base.

7.2 Protein and Tryptophan

A systematic review and meta-analysis found that tryptophan, vitamin D, omega-3, zinc, and antioxidants may enhance sleep quality by decreasing sleep latency and wakefulness after sleep onset, increasing sleep efficiency, and extending total sleep time. Tryptophan, obtained from dietary protein sources such as turkey, eggs, dairy, seeds, and legumes, is a precursor to serotonin and melatonin — both key in mood regulation and sleep architecture disrupted in burnout states.

7.3 Antioxidant-Rich Foods

Consequences of burnout include increased allostatic load, systemic inflammation, and excitotoxicity. Dietary antioxidants — including vitamin C, vitamin E, selenium, and polyphenols from fruits, vegetables, and whole grains — are widely discussed in the context of mitigating oxidative stress, though specific intervention trials in burnout populations do not yet exist in the peer-reviewed literature.

8. Lifestyle Factors Discussed in Authoritative Sources

8.1 Sleep

Sleep disruption is both a symptom and a driver of burnout. Chronic stress interferes with REM sleep, the stages most involved in memory consolidation and emotional regulation. Poor sleep raises cortisol further, which impairs sleep quality again. Over weeks and months, this feedback loop compounds the cognitive and emotional effects of burnout considerably.

8.2 Exercise

Active coping strategies promoting mental resilience and adaptive behavior, stress-reducing activities, improving work conditions, and reducing exposure to work stressors together may alleviate the distress of burnout and should be introduced early in the clinical course of burnout syndrome.

8.3 Work Conditions and Social Support

The high demands loaded upon employees may lead to burnout as well as a decline in health and increased absenteeism. Nevertheless, the availability of resources can stimulate positive results at work such as commitment to the job and a reduction in absenteeism and burnout.

Adequate management of work demands, particularly excessive workload, time pressure, and lack of staff, can lead to prevention of burnout and reduced job satisfaction in health professionals, and contribute to better quality of patient care.

8.4 Mindfulness and Stress-Reducing Practices

Regular meditation practice has been associated with improved immune functions and may assist in treating disorders like burnout and chronic fatigue. This claim is based on review-level commentary and should be interpreted cautiously, as the methodological quality of individual mindfulness-burnout studies varies considerably.

9. Limitations and Evidence Gaps

Limitations of studies on burnout's neurobiological correlates include variability in study populations, low specificity of burnout measures, and mostly cross-sectional studies precluding examination of changes across the course of burnout.

A review of 182 studies of physician burnout identified 142 different definitions of burnout, underlining the great heterogeneity in diagnostic criteria for the condition. This definitional heterogeneity is a significant constraint: it means that nutrient or botanical studies enrolling "stressed" adults or "fatigued" populations cannot be straightforwardly extrapolated to clinically defined burnout recovery.

No randomized controlled trials to date have been designed specifically to evaluate nutritional or herbal interventions in a population diagnosed with ICD-11 burnout as a primary outcome. All nutritional and botanical evidence reviewed here comes from studies in generally stressed, fatigued, or mildly depressed populations, and its relevance to burnout recovery is inferential.

References

• World Health Organization — Burn-out an "occupational phenomenon": International Classification of Diseases
• AIHA — WHO Classifies Burn-Out as an "Occupational Phenomenon"
• PMC — Examining the evidence base for burnout
• PMC — Burnout phenomenon: neurophysiological factors, clinical features, and aspects of management
• ResearchGate — Neurobiological correlates of burnout
• PubMed — The HPA-axis and immune function in burnout (Mommersteeg et al.)
• PubMed — Burnout Is Associated with Reduced Parasympathetic Activity and Reduced HPA Axis Responsiveness (de Vente et al., 2015)
• PubMed — Neuro-endocrine correlates of burnout
• PubMed — Cortisol in burnout and vital exhaustion: an overview
• PubMed — Clinical burnout is not reflected in the cortisol awakening response (Mommersteeg et al., 2006)
• PubMed — Physiological differences between burnout patients and healthy controls
• PMC — Physical, psychological and occupational consequences of job burnout: A systematic review of prospective studies
• PMC — Seeing burnout coming: early signs and recognition strategies in health professionals
• PMC — Occupational Burnout in Healthcare Workers, Stress and Other Symptoms of Work Overload during the COVID-19 Pandemic in Poland
• PMC — Positive psychology in the working environment: Job demands-resources theory, work engagement and burnout
• PMC — Superiority of magnesium and vitamin B6 over magnesium alone on severe stress in healthy adults with low magnesemia (Pouteau et al., 2018)
• PubMed — Impact of magnesium supplementation, in combination with vitamin B6, on stress and magnesium status (Noah et al., 2021)
• PMC — Effect of magnesium and vitamin B6 supplementation on mental health and quality of life in stressed healthy adults (post-hoc RCT analysis)
• PMC — A Prospective, Randomized Double-Blind, Placebo-Controlled Study of Safety and Efficacy of Ashwagandha Root in Reducing Stress and Anxiety in Adults (Chandrasekhar et al., 2012)
• PMC — An investigation into the stress-relieving and pharmacological actions of an ashwagandha extract (Lopresti et al., 2019)
• PMC — Effects of Ashwagandha Supplements on Cortisol, Stress, and Anxiety Levels in Adults: A Systematic Review and Meta-Analysis
• PMC — Withania somnifera (Ashwagandha) supplementation: a review of its mechanisms, health benefits, and role in sports performance
• MDPI Nutrients — Effects of Withania somnifera Extract in Chronically Stressed Adults: A Randomized Controlled Trial (2024)
• ScienceDirect — Effects of Ashwagandha on stress and anxiety: A systematic review and meta-analysis (2024)
• PMC — Multicenter, open-label, exploratory clinical trial with Rhodiola rosea extract in patients suffering from burnout symptoms
• PubMed — Rhodiola rosea for physical and mental fatigue: a systematic review (Punja et al., 2012)
• PMC — Rhodiola rosea for physical and mental fatigue: a systematic review (full text, 2012)
• PMC — The Effectiveness of Rhodiola rosea L. Preparations in Alleviating Various Aspects of Life-Stress Symptoms and Stress-Induced Conditions
• PubMed — Effects of multi-herb and ashwagandha root formulas on stress modulation: a randomized, double-blind, placebo-controlled clinical study (2026)
• PMC — Food for Mood: Relevance of Nutritional Omega-3 Fatty Acids for Depression and Anxiety
• MDPI — Omega-3 Fatty Acids and Mood Disorders: A Critical Narrative Review (2026)
• Harvard Health — Omega-3 fatty acids for mood disorders
• PMC — The mediating effect of BMI in serum vitamin D related sleep deprivation based on the NHANES database
• PMC — Dietary Supplement Interventions and Sleep Quality Improvement: A Systematic Review and Meta-Analysis
• PMC — Quality of Working Life, Psychosocial Factors, Burnout Syndrome and Emotional Intelligence
• PMC — Burnout and Work Demands Predict Reduced Job Satisfaction in Health Professionals Working in a Surgery Clinic